GoodRx Holdings IncGDRX
Price$3.27Intrinsic value$3.086% below price

Valuation

How Intrinsic Value compares with model outputs

Intrinsic Value $3.08median of 6 methods · middle span $1-$6based on filings through 30 Jun 2026
Market Price $3.27Price as of 1 Oct 2026
Margin of Safety -5.8%as of 1 Oct 2026

Valuation methods vs. Market Price

Company vs. peer median Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions

ParameterValue
Years 1–5: analyst growth pathFive-year total matches analyst consensus exactly. Year 1: 2.5% (near-term consensus, capped) · years 2–5: 6.3%/yr (balance of the path).5.5% per year
Years 6–10: glide to demonstrated growth
Per-year rates
Yr 65.6%Yr 75.0%Yr 84.3%Yr 93.7%Yr 103.0%
6.3% → 3.0%
Years 11–20: glide to long-run rate
Per-year rates
Yr 113.0%Yr 123.0%Yr 133.0%Yr 143.0%Yr 153.0%Yr 163.0%Yr 173.0%Yr 183.0%Yr 193.0%Yr 203.0%
3.0% → 3.0%
Beyond year 20: terminal growthPerpetual long-run rate3.0%
Historical EPS growth (multi-year median)median of 2 windows (6/7y) (limited history)-18.6%
Discount rate (cost of equity) 11.2%
Volatility vs market (adjusted beta)1.39

Valuation Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Assumptions Sandbox Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up

Compare with peers

Search any company to compare valuation, profitability, returns, growth, and financial strength side by side.

Compare the target company plus 1 peer. Sign in / Sign up to compare a maximum of 3 peers.

Best in rowHigher is betterLower is better—Data not available
TargetGoodRx Holdings IncGDRXHealth Care
Valuation
P/E54.5×
P/S1.5×
P/B1.8×
EV / Revenue1.7×
EV / EBITDA7.1×
Profitability
Gross margin92.8%
Operating margin11.0%
Net margin2.1%
FCF margin25.1%
Returns
ROE2.5%
ROA0.7%
ROIC1.9%
Growth
Revenue growth (YoY)-0.9%
5-yr fwd EPS growth5.5%
Financial strength
Debt / Equity0.75×
Current ratio1.38×
Altman Z-Score0.3
Interest coverage—
Dividend yield—

Best value in each row is highlighted. Figures are periodic snapshots from the same filings used across each dossier; a dash means the figure is not available.

AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.